First China Pharmaceutical Group (FCPG) Annual Balance Sheets

Annual · GAAP · USD millions
Access FCPG quarterly Balance Sheets →
Examining balance sheet movements between First China Pharmaceutical Group and reveals how Mar 31 2010 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Mar 31 2010)
Assets
Cash & cash equivalent0.16
Restricted Cash and Cash Equivalents, Current0.68
Cash & Short-term Investments0.00
Inventories4.67
Total Current Assets5.51
Equipment/Property/Plant Net0.00
Intangible Assets0.00
Total Assets5.52
Liabilities
Other Accounts Payable AndAccrued Liabilities0.44
Short-term Debt DE10.73
Accrued Income Taxes, Current TA2.02
Total Current Liabilities11.67
Total Long-term Debt0.00
Total Liabilities11.67
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock0.22
Retained Earnings / Accumulated Deficit-6.54
Accumulated Other Comprehensive Income0.12
Other Equity0.12
Common Stockholder's Equity-6.16
Total Stockholder's Equity-6.16
Liabilities & Stockholder's Equity5.52
4 historic quarters locked

Sign in to unlock the full First China Pharmaceutical Group balance sheet history.

About FCPG Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License